Clinical Effects of Vinblastine in Chorionic Tumors

Hasegawa, Toshio; Ogawa, Genichi; Kobayashi, Takashi; Natsume, Misao; Ashidaka, Y; Koga, Kohachiro; G, Nozue

doi:10.1007/978-3-642-85907-6_33

Search citation statements

Order By: Relevance

Paper Sections

Select...

Registry and Follow-up System1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

1985

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In Japan, the hospital registry of the trophoblastic tumors began in 1955 [13,14]. Ishizuka and Kawashima [ 1,2,4-61, in 1962, established the regionalized registry and follow-up system in Aichi Prefecture in order to know the incidence of the trophoblastic diseases in a given population and to improve the prognosis of choriocarcinoma patients arising after hydatidiform mole by means of early detection and early treatment.…”

Section: Registry and Follow-up Systemmentioning

confidence: 99%

Registry and follow‐up systems of trophoblastic disease in Japan

Kawashima

Maeda

Fujii

1985

Seminars in Surgical Oncology

View full text Add to dashboard Cite

With recent progress in chemotherapy, the prognosis of patients with trophoblastic disease has greatly improved, but the remission rate of patients with choriocarcinoma remains unfavorable. To improve the prognosis of these patients, early detection and early treatment are essential. Under the leadership of the Committee of Trophoblastic Disease of the Japan Society of Obstetrics and Gynecology, regional registries of trophoblastic disease were started in 1974. By 1982 14 prefectures with a total population of 46,893,620 were included in the registry. The early detection and treatment and follow-up made possible by the registry in addition to the introduction of advanced chemotherapy may be responsible for a rapidly decreasing trend in the death rate from this disease.

show abstract

Section: Registry and Follow-up Systemmentioning

confidence: 99%